Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam L Halberstadt

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
ACS Chemical Neuroscience|October 29, 2019
DARK Classics in Chemical Neuroscience: NBOMesChristian B M Poulie, Anders A Jensen, Adam L Halberstadt, et al.
Psychopharmacology|December 15, 2010
Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in miceAdam L Halberstadt, Virginia D Lehmann-Masten, Mark A Geyer, et al.
Journal of Natural Products|March 5, 2021
Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic ActivityJanis Fricke, Alexander M Sherwood, Adam L Halberstadt, et al.
Behavioural Brain Research|May 10, 2012
Four factors underlying mouse behavior in an open fieldShoji Tanaka, Jared W Young, Adam L Halberstadt, et al.
Neuropharmacology|April 20, 2011
Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophreniaMaarten van den Buuse, Emma Ruimschotel, Sally Martin, et al.
Journal of Affective Disorders|November 30, 2013
Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorderJordy van Enkhuizen, Mark A Geyer, Adam L Halberstadt, et al.
Psychopharmacology|July 8, 2008
Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitorsAdam L Halberstadt, Mahalah R Buell, Virginia L Masten, et al.
Neuropharmacology|March 3, 2018
Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogsLandon M Klein, Nicholas V Cozzi, Paul F Daley, et al.
Psychoneuroendocrinology|September 24, 2025
Chronic corticosterone impaired effortful motivation and risky decision-making in miceMichael N Noback, Adam L Halberstadt, Samuel A Barnes, et al.
Drug Testing and Analysis|December 3, 2024
Analytical and Pharmacological Characterization of 1-(Furan-2-Carbonyl)-LSD (1F-LSD) and Comparison With 1-(Thiophene-2-Carbonyl)-LSD (1T-LSD)Simon D Brandt, Pierce V Kavanagh, Sarah Gare, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
ACS Chemical Neuroscience|October 29, 2019
DARK Classics in Chemical Neuroscience: NBOMesChristian B M Poulie, Anders A Jensen, Adam L Halberstadt, et al.
Psychopharmacology|December 15, 2010
Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in miceAdam L Halberstadt, Virginia D Lehmann-Masten, Mark A Geyer, et al.
Journal of Natural Products|March 5, 2021
Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic ActivityJanis Fricke, Alexander M Sherwood, Adam L Halberstadt, et al.
Behavioural Brain Research|May 10, 2012
Four factors underlying mouse behavior in an open fieldShoji Tanaka, Jared W Young, Adam L Halberstadt, et al.
Neuropharmacology|April 20, 2011
Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophreniaMaarten van den Buuse, Emma Ruimschotel, Sally Martin, et al.
Journal of Affective Disorders|November 30, 2013
Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorderJordy van Enkhuizen, Mark A Geyer, Adam L Halberstadt, et al.
Psychopharmacology|July 8, 2008
Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitorsAdam L Halberstadt, Mahalah R Buell, Virginia L Masten, et al.
Neuropharmacology|March 3, 2018
Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogsLandon M Klein, Nicholas V Cozzi, Paul F Daley, et al.
Psychoneuroendocrinology|September 24, 2025
Chronic corticosterone impaired effortful motivation and risky decision-making in miceMichael N Noback, Adam L Halberstadt, Samuel A Barnes, et al.
Drug Testing and Analysis|December 3, 2024
Analytical and Pharmacological Characterization of 1-(Furan-2-Carbonyl)-LSD (1F-LSD) and Comparison With 1-(Thiophene-2-Carbonyl)-LSD (1T-LSD)Simon D Brandt, Pierce V Kavanagh, Sarah Gare, et al.
Pageof 9